Verismo Therapeutics Expands Scientific Team to Advance its KIR-CAR Platform for the Treatment of Solid Tumors

/PRNewswire/ -- Verismo Therapeutics, Inc., a recent Penn spin-out behind a novel naturally inducible multi-chain KIR-CAR platform technology for CAR T-cells,...

Related Keywords

University Of Pennsylvania ,Pennsylvania ,United States ,Philadelphia ,Raymond Luke ,Jun Xu ,Bryan Kim ,Alyson Kuritz ,Product Development Laboratory ,Prnewswire Verismo Therapeutics Inc ,Senior Director ,Translational Science ,Verismo Therapeutic Chief Executive Officer ,First In Human Clinical Trial ,Associate Director ,Process Development ,Clinical Studies ,Nature Medicine ,Lewis Katz School ,Verismo Therapeutics ,Natural Killer Cell ,